The genetic alterations of vitamin D receptor (VDR) are related with the growth of long bone. There were a lot of reports regarding an association of polymorphisms in the VDR promoter with many disorders, but not with idiopathic short stature (ISS). We investigated the association of them with ISS. A total of 50 subjects, including 29 ISS patients and 21 healthy controls with their heights within the normal range was recruited. We selected two single nucleotide polymorphisms (SNPs) from VDR promoter (rs11568820 at the Cdx-2 binding site upstream of exon 1e and rs4516035 at -1012 upstream of exon 1a) as candidates, respectively. In genotype analysis, the frequency of A/A genotype at the Cdx-2 binding site locus (rs11568820) upstream of exon 1e of VDR was decreased to 6.9% in ISS patients (28.6% in controls) (P = 0.027). The genetic variation at the Cdx-2 binding site of VDR promoter can be a contributing factor of growth of height.
INTRODUCTION
Height is a complex trait influenced by various nutritional, en vironmental, and genetic factors. The heritability of height is re ported to be up to 75% (1). Short stature is not a significant me dical disorder, but the most common cause for referrals to pe diatric endocrinologist. There are many progressing investiga tions on the mechanism and treatment, as well as, genetics for short stature.
The vitamin D receptor (VDR) plays a role in mineralization of the bone, intestinal calcium absorption, and cell differentia tion (2) . The VDR gene is located on chromosome 12q13.1 and consists of 5´ promoter, coding exons, and 3´ regulatory region. Many VDR polymorphisms are found through restriction frag ment length polymorphism (RFLP) or sequence analyses; FoKI in the start codon (3), BsmI, ApaI, and TaqI polymorphism in 3´ untranslated region (4) , and Cdx2 polymorphism in the VDR 1a promoter (5) . There were a lot of reports regarding an associ ation of polymorphisms in the VDR promoter with many disor ders, such as rickets (6) , osteoporosis (7) , breast cancer (8) , and allergic diseases (9, 10) . The functional studies of each polymor phism in VDR gene are in progress and the VDR polymorphisms have been associated with adult height in several studies (1, 2, 1114) . Most studied the VDR single nucleotide polymorphisms (SNPs) on coding exons, and 3´ regulatory region, not 5´ pro moter. Promoter regions regulate the transcriptional activity of the VDR and seem to have an important effect on the height. The purpose of this study was to determine whether polymor phisms in the VDR promoter are associated with idiopathic short stature (ISS) in Korean children.
MATERIALS AND METHODS

Subjects
From July 2008 through July 2009, 50 healthy Korean children (26 males and 24 females) who visited for growth evaluation at Kyung Hee University Hospital at Gangdong participated in this study. They got growth hormone stimulation test with insulin and Ldopa, and 29 patients were classified under ISS patients by the laboratory finding that the peak serum GH level was over 10 ng/mL. ISS is defined as a condition in which the height of the individual is more than 2 standard deviations (SD) below the corresponding mean height for a given age, sex, and popu lation group, without evidence of systemic, endocrine, nutri tional, or chromosomal abnormalities (15, 16) . Height (cm) was measured using standardized equipment (Harpenden stadi ometer) without shoes. The bone age was assessed by radio graphs of the hand and wrist, using a method of Greulich 
Genotyping
The genotyping was screened using a single base primer exten sion assay using ABI PRISM SNaPShot Multiplex kit (ABI, Fos ter City, CA, USA), according to the manufacturer's recommen dation. Briefly, the genomic DNA flanking the interested SNP was amplified with PCR reaction with Forward and Reverse pri mer pairs and standard PCR reagents in 10 microliter reaction volume, containing 10 ng of genomic DNA, 0.5 pM of each oli gonucleotide primer, 1 microliter of 10 × PCR buffer, 250 μM dNTP (2.5 mM each) and 0.25 unit iStarTaq DNA Polymerase (5 unit/ μL) (iNtRON Biotechnology, Seongnam, Kyungkido, Korea). The PCR reactions were carried out as follows: 10 min at 95°C for 1 cycle, and 35 cycles on 95°C for 30 sec, Tm°C for 1 min, 72°C for 1 min, followed by 1 cycle of 72°C for 10 min. After amplifi cation, the PCR products were treated with 1 unit each of shrimp alkaline phosphatase (SAP) (USB Corporation, Cleveland, OH, USA) and exonuclease I (USB Corporation) at 37°C for 75 min and 72°C for 15 min to purify the amplified products. One mi croliter of the purified amplification products were added to a SNaPshot Multiplex Ready reaction mixture containing 0.15 pM of genotyping primer for primer extension reaction. The primer extension reaction was carried out for 25 cycles of 96°C for 10 sec, 50°C for 5 sec, and 60°C for 30 sec. The reaction products were treated with 1 unit of SAP at 37°C for 1 hr and 72°C for 15 min to remove the excess fluorescent dye terminators. One mi croliter of the final reaction samples containing the extension products were added to 9 microliter of HiDi formamide (ABI, Foster City, CA, USA). The mixture was incubated at 95°C for 5 min, followed by 5 min on ice and then analyzed by electropho resis in ABI Prism 3730xl DNA analyzer. Analysis was carried out using Genemapper software (version 4.0; Applied Biosys tems). Table 1 shows the primer sets and Tm used for the SNaP shot assay.
Statistical analysis
Statistical analysis was performed using SAS ver.8.02. The de mographic characteristics of the control and patient groups were compared with KruskallWallis test. Each result was presented as the mean ± standard deviations. The value of P < 0.05 is con sidered as statistically significant. The frequencies of allele and genotype, and the departures of the genotype distribution from HardyWeinberg equilibrium for each SNP were analyzed us ing the chisquare test or Fisher's exact test. The genotypespe cific risks were estimated as the odds ratios with associated 95% confidence intervals using conditional logistic regression anal ysis.
Ethics statement
This study was approved by the institutional review board at Kyung Hee University Hospital at Gangdong (KHNMC IRB 2008 018). All subjects and parents provided informed consent be fore the study commen cement. Table 2 shows demographic characteristics of subjects. Twenty nine ISS patients consist of 12 males and 17 females. In 21 con trols, there were 14 males and 7 females. The bone age (8.5 ± 2.6 yr) in ISS patients was less than chronological age (9.3 ± 1.9 yr), but no significant statistical differences. Further, there were no differences between bone age (9.5 ± 2.1 yr) and chronological age (9.4 ± 2.8 yr) in the control group. In height Z score and mid parental target height Z score, the values of ISS patients were less than those of the controls (P < 0.001).
RESULTS
Subjects
Distribution of the VDR polymorphisms
Two SNPs were analyzed; rs11568820 at the Cdx2 binding site upstream of exon 1e and rs4516035 at 1012 upstream of exon 1a. The distribution of genotypes at the Cdx2 binding site SNP locus were following in ISS patients; G/G, 37.9%; G/A, 55.2% and A/A, 6.9%; in controls G/G, 42.9%; G/A, 28.6%; and A/A, 28.6%. In ISS patients, the genotype with A/A allele at 1012 SNP locus was observed in 93.1% and with G/A allele were observed in 6.9%. In controls, genotype with A/A allele at 1012 SNP lo cus was observed in 100% (Table 3 ). In the Cdx2 binding site SNP locus, adjusted odds ratio of recessive genotype was 0.098 (adjusted P = 0.027) and the frequency of A/A genotype at the 9.4 ± 2.8 9.3 ± 1.9 0.45 Bone age (yr, mean ± SD) 9.5 ± 2. Cdx2 binding site locus (rs11568820) upstream of exon 1e of VDR was decreased in ISS patients (Table 4) . The VDR gene is composed of 5´ promoter (from exon 1a through f), coding exons (exon 29), and 3´ untranslated region in the chromosome 12q13.1. In each nucleotide in the VDR gene, the polymorphisms may accidentally occur. As a result of the VDR gene polymorphisms, defined as genetic variants that ap pear in at least 1% of the population, it affects the level of the VDR protein in the target organs and causes numerous diseas es. For example, the FoKI RFLP in coding exon regulates the length and activity of the VDR protein as a transcription factor (17) . There are some studies of relations between the FoKI RFLP and diseases, such as psoriasis (18) and cancer (19) . Another example is the BsmI, ApaI, and TaqI polymorphism in 3´ un translated region, which is related to the regulation of mRNA stability and halflife and resulted in a better response to vita min D in the target tissue (17) . It is one of the widely known roles that the polymorphism regulates osteocalcin, a hormone to re lease more insulin in the pancreas and a biochemical marker for bone formation (20) . In several studies, the association be tween the abovementioned VDR gene polymorphisms and height has been investigated (13, 13, 14, 21) . Minamitani et al. (22) investigated that FoKI RFLP in exon 2 polymorphism is as sociated with adult height in healthy Japanese female. Suarez et al. (23) also studied association between BsmI polymorphism of the VDR gene and height in Caucasian fullterm male babies.
DISCUSSION
The role of promoter region, one part of the VDR gene, is a regulation of VDR gene transcriptional activity in the intestinal mucosa as well (5, 2427) . The wellknown two SNPs located in the VDR promoter region are rs11568820 located at Cdx2 bind ing site locus and rs4516035 located at 1012 locus. These SNPs are also related to bone mineral density (BMD) and modulation of calcium homeostasis (2427). In this study, we hypothesized that promoter region of the VDR gene is also associated with hei ght like other region of the VDR gene.
The Cdx2 gene that plays a role as an intestinalspecific tran scription factor was detected by Arai et al. (5) (5) also found that the dif ference of promoter functional activity in the CdxG genotype was 70% of the CdxA genotype. The increased level of CdxA gene expression may relate to an increased BMD in postmeno pausal women, but not directly. In the present study, the fre quency of CdxA allele was increased in the control group com pared with ISS patients (Table 3 , P < 0.05). It suggested that the Cdx2 polymorphism may be related with height as a predictor of ISS.
In the present study, there was no significant statistical differ ence between SNPs at 1012 locus with ISS patients and with controls (Table 3) . We found different results of studies of the 1012 locus of the VDR promoter. According to Jehan et al. (26) , SNPs at 1012 locus may be associated with height and serum calcium level. The 1012A VDR promoter had a role of increas ed VDR transcriptional activity, and it affected increased growth and serum calcium level regardless of the calcium intake. Wher eas, Dempfle et al. (11) presented that the 1012 VDR polymor phism genotype is not significantly associated with height, but strong overtransmission only to female. With regard to associa tion with height and vitamin D status in adolescent girls, D'Alésio et al. (12) studied two SNPs located at 1521 (G/C) and 1012 (A/ G) loci in the VDR promoter. They are located closely and linked to each genotype. Compared with 1521GG/1012AA girls, height in 1521CC/1012GG girls was smaller during the pubertal growth spurt up to adult height.
There are several limitations in this study. First, there were relatively small samples and the difference of number of gen der between the patient group and the control group. Second, we could not distinguish between the constitutional delay of growth and puberty, and the familial short stature clearly. Fur ther studies would be required in large population cohort and needed to compare with gender. In summary, the VDR genotype, the frequency of A/A geno type at the Cdx2 binding site locus (rs11568820) upstream of exon 1e of VDR was decreased in ISS patients. Therefore, the genetic variation at the Cdx2 binding site of the VDR promoter can be a contributing factor of growth of height in Korean chil dren.
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